CClinicalTrials.gg
CompletedNCT07204470Updated Apr 21, 2026

The Effects of Four Instant Maize Porridges on Satiety Measures

An interventional study of Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period. in Satiety, sponsored by PepsiCo Global R&D. Completed at 1 site in South Africa. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by PepsiCo Global R&D · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This study is designed to test the hypothesis that whole-grain forms of maize meal enhance and prolong satiety post-meal consumption.

02

Conditions studied

  • Satiety

Keywords

  • whole grain
  • appetite
  • glycemic index
  • leptin
  • ghrelin
03

In context

Lead sponsor

PepsiCo Global R&D is the lead sponsor of 101 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Availability to participate on the test days
  • Interest and consent to participate in the study
  • Participants must be willing to fast 10 hours overnight before the test breakfast meal (only water allowed)
  • Products and meals high in fiber, alcohol and strenuous exercise should be avoided 24 hours before the test
  • Age 18-35 years
  • Healthy BMI: 18.5-24.9 kg/m2
  • Equal split, males and females

Exclusion criteria

Exclusion Criteria:

  • Pregnancy; breast-feeding
  • History of gastrointestinal disease having an impact on food absorption or digestion; anorexia nervosa or bulimia nervosa
  • Anaemia
  • Hypoglycaemia
  • Cardiovascular disease; elevated plasma glucose; unstable thyroid function
  • Abnormal/irregular menstrual cycle
  • Substance abuse
  • Being on medication which influences appetite
  • Depression; smoking
  • Participation in any weight altering program; weight gain or loss > 5 kg in 3 months prior to enrolment
  • History of intestinal discomfort when consuming relatively small (e.g., \<10g) amounts of non-digestible fibres
  • Any known food allergies or intolerances such as wheat or soy; special diets prescribed by medical practitioner
  • Any intensive physical training program
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Whole grain maize porridge prepared with cold water

    White Star Whole Grain Instant Maize Porridge Original

    Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

  • Experimental
    Whole grain maize porridge prepared with hot water

    White Star Whole Grain Instant Maize Porridge Original

    Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

  • Experimental
    Smart Food

    FUTURELIFE Smart Food Original

    Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

  • Experimental
    Instant Maize Porridge - reduced sugar formulation (WSIP)

    White Star Instant Maize Porridge Original- reduced sugar formulation (WSIP)

    Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

Interventions

  • OtherBreakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

    Cereal is in porridge form. One 350 ml bottle of water provided for the 4 hour test period 7:00-11:00 a.m.. Control dinner meal consumed the prior evening, then fast 10 hours overnight before visiting the test facility on four test days one week apart.

06

What researchers measure

Primary outcomes

  1. Satiety -Appetite

    Self-reported appetite ratings using a 100 mm visual analog scale (VAS) questionnaire with 3 items: desire to eat rated from very weak to very strong, hunger rated from not at all to extremely, and fullness rated from not at all to extremely.

    Time frame: On each of four testing days, in fasted state, immediately after the standardised breakfast (0), and at 120 and 240 min after the breakfast

  2. Satiety -Biomarkers: Leptin

    Blood by venipuncture to measure the appetite-regulating hormone leptin in nanograms per milliliter

    Time frame: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  3. Satiety -Biomarkers: Ghrelin

    Blood by venipuncture to measure the appetite-regulating hormone ghrelin in picograms per milliliter

    Time frame: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  4. Satiety - glycaemic parameters: Glucose

    Blood samples obtained by venipuncture in millimoles per liter

    Time frame: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  5. Satiety - glycaemic parameters: Insulin

    Serum samples obtained by venipuncture in microunits per milliliter

    Time frame: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

Secondary outcomes

  1. Anthropometric measurements - BMI

    Body mass index calculated from kg weight and cm height

    Time frame: Test Day 1 only prior to porridge consumption

  2. Anthropometric measurements - WHR

    Waist-hip ratio in centimeters

    Time frame: Test Day 1 only prior to porridge consumption

  3. Anthropometric measurements - Fat Mass

    Body composition measurement

    Time frame: Test Day 1 only prior to porridge consumption

  4. Dietary intake habits-QFFQ

    Interviewer-administered, completed once using a quantified food frequency questionnaire (QFFQ) of 140 typically consumed food items by type/brand, cooking methods, frequency, and the amount of all food and drink consumed in the past 4 weeks converted to grams per week per food item

    Time frame: The protocol allows for completion prior to the first test day, or instead at any one of the four test days. There is no particular time point requirement that it be done at baseline nor within a certain window after test meal consumption.

  5. Dietary intake habits-24 hour recall

    Using a quantified food frequency questionnaire (QFFQ)

    Time frame: Completed at each of the four test days. There is no particular time point requirement that it be done at baseline nor within a certain window after test meal consumption.

07

Study locations

1 site
  • U. Pretoria
    Pretoria, 0083, South Africa
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07204470
Lead sponsor
PepsiCo Global R&D
Responsible party
Sponsor
First posted
Oct 2, 2025
Start date
Jul 21, 2025
Primary completion
Aug 15, 2025
Completion
Aug 15, 2025
Last update
Apr 21, 2026

Study contacts

Henrietta L de Kock
principal investigator · U Pretoria

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion